skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Efficacy and safety of twice-daily treatment with canagliflozin, a sodium glucose co-transporter 2 inhibitor, added on to metformin monotherapy in patients with type 2 diabetes mellitus
Efficacy and safety of twice-daily treatment with canagliflozin, a sodium glucose co-transporter 2 inhibitor, added on to metformin monotherapy in patients with type 2 diabetes mellitus
Material Type:
Article 		Add to My Research

Efficacy and safety of twice-daily treatment with canagliflozin, a sodium glucose co-transporter 2 inhibitor, added on to metformin monotherapy in patients with type 2 diabetes mellitus

Journal of clinical & translational endocrinology, 2014-06, Vol.1 (2), p.54-60 [Peer Reviewed Journal]

The Authors ;2014 The Authors ;2014 The Authors 2014 ;ISSN: 2214-6237 ;EISSN: 2214-6237 ;DOI: 10.1016/j.jcte.2014.04.001 ;PMID: 29159083

Full text available

Citations Cited by
2
Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial
Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial
Material Type:
Article 		Add to My Research

Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial

The Lancet (British edition), 2013-09, Vol.382 (9896), p.941-950 [Peer Reviewed Journal]

Elsevier Ltd ;2013 Elsevier Ltd ;2014 INIST-CNRS ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Sep 14, 2013 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(13)60683-2 ;PMID: 23850055 ;CODEN: LANCAO

Full text available

Citations Cited by
3
Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)—A randomized placebo-controlled trial
Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)—A randomized placebo-controlled trial
Material Type:
Article 		Add to My Research

Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)—A randomized placebo-controlled trial

The American heart journal, 2013-08, Vol.166 (2), p.217-223.e11 [Peer Reviewed Journal]

Mosby, Inc. ;2013 Mosby, Inc. ;Copyright © 2013 Mosby, Inc. All rights reserved. ;Copyright Elsevier Limited Aug 2013 ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2013.05.007 ;PMID: 23895803 ;CODEN: AHJOA2

Full text available

Citations Cited by
4
Diabetes-Related Composite Quality End Point Attainment: Canagliflozin Versus Sitagliptin Based on a Pooled Analysis of 2 Clinical Trials
Diabetes-Related Composite Quality End Point Attainment: Canagliflozin Versus Sitagliptin Based on a Pooled Analysis of 2 Clinical Trials
Material Type:
Article 		Add to My Research

Diabetes-Related Composite Quality End Point Attainment: Canagliflozin Versus Sitagliptin Based on a Pooled Analysis of 2 Clinical Trials

Clinical therapeutics, 2015-05, Vol.37 (5), p.1045-1054 [Peer Reviewed Journal]

Elsevier HS Journals, Inc. ;2015 Elsevier HS Journals, Inc. ;Copyright © 2015 Elsevier HS Journals, Inc. All rights reserved. ;Copyright Elsevier Limited May 2015 ;ISSN: 0149-2918 ;EISSN: 1879-114X ;DOI: 10.1016/j.clinthera.2015.02.020 ;PMID: 25795432

Full text available

Citations Cited by
5
Impact of Age and Estimated Glomerular Filtration Rate on the Glycemic Efficacy and Safety of Canagliflozin: A Pooled Analysis of Clinical Studies
Impact of Age and Estimated Glomerular Filtration Rate on the Glycemic Efficacy and Safety of Canagliflozin: A Pooled Analysis of Clinical Studies
Material Type:
Article 		Add to My Research

Impact of Age and Estimated Glomerular Filtration Rate on the Glycemic Efficacy and Safety of Canagliflozin: A Pooled Analysis of Clinical Studies

Canadian journal of diabetes, 2016-06, Vol.40 (3), p.247-257 [Peer Reviewed Journal]

Canadian Diabetes Association ;2015 Canadian Diabetes Association ;Copyright © 2015 Canadian Diabetes Association. Published by Elsevier Inc. All rights reserved. ;ISSN: 1499-2671 ;EISSN: 2352-3840 ;DOI: 10.1016/j.jcjd.2015.11.005 ;PMID: 27052454

Full text available

Citations Cited by
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait